mil60

· Beijing Mabworks Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mil60, covering 2023-01-31 to 2023-01-31. Get the full timeline:

Most recent: Clinical Trial Update: mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer [Phase 3]